|Mr. Jonathan Summers||Exec. Chairman & CEO||N/A||N/A||N/A|
|Mr. Bobby Doyon||Legal Counsel & Non-Independent Director||N/A||N/A||N/A|
|Mr. Michael Winslow Kinley C.A., CPA||CFO & Director||N/A||N/A||1951|
|Mr. Tanek Amin||Head of Corp. Devel.||N/A||N/A||N/A|
|Mr. Paulo Martins||CEO & Country Director of its operations in Portugal||N/A||N/A||N/A|
|Ms. Julie Lemieux||VP of Canadian Operations & Corp. Sec.||N/A||N/A||N/A|
EXMceuticals Inc. engages in the production of cannabinoid formulations. The company primarily focuses around the matching of natural bioactive ingredients extracted from the cannabis plant with the needs of the nutraceutical, cosmeceutical, therapeutic, and pharmaceutical industries. It focuses on the production of CBD, a non-psychoactive cannabinoid that has been proven effective against acne, anxiety, depression, epilepsy, and degenerative diseases, such as Parkinson's; and THC, a psychoactive cannabinoid ingredient that has been proven effective in the fields of pain management, appetite control, anxiety, and managing side effects of chemotherapy. The company was incorporated in 2008 and is headquartered in Quebec, Canada.
EXMceuticals Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.